ultralife corp. - ULBI

ULBI

Close Chg Chg %
6.59 0.09 1.37%

Closed Market

6.68

+0.09 (1.37%)

Volume: 12.54K

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: ultralife corp. - ULBI

ULBI Key Data

Open

$6.43

Day Range

6.41 - 6.68

52 Week Range

4.07 - 9.51

Market Cap

$111.27M

Shares Outstanding

16.66M

Public Float

9.91M

Beta

0.72

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.35

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

70.99K

 

ULBI Performance

1 Week
 
4.70%
 
1 Month
 
27.24%
 
3 Months
 
13.61%
 
1 Year
 
47.79%
 
5 Years
 
-18.83%
 

ULBI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About ultralife corp. - ULBI

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the following segments: Battery and Energy Products and Communications System. The Battery and Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment comprises radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.

ULBI At a Glance

Ultralife Corp.
2000 Technology Parkway
Newark, New York 14513-9113
Phone 1-315-332-7100 Revenue 191.16M
Industry Electrical Products Net Income -5,898,000.00
Sector Producer Manufacturing 2025 Sales Growth 16.237%
Fiscal Year-end 12 / 2026 Employees 678
View SEC Filings

ULBI Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.498
Price to Book Ratio 0.733
Price to Cash Flow Ratio 8.68
Enterprise Value to EBITDA 9.442
Enterprise Value to Sales 0.727
Total Debt to Enterprise Value 0.381

ULBI Efficiency

Revenue/Employee 281,945.428
Income Per Employee -8,699.115
Receivables Turnover 5.631
Total Asset Turnover 0.874

ULBI Liquidity

Current Ratio 2.834
Quick Ratio 1.387
Cash Ratio 0.25

ULBI Profitability

Gross Margin 23.281
Operating Margin 4.823
Pretax Margin -4.393
Net Margin -3.085
Return on Assets -2.697
Return on Equity -4.468
Return on Total Capital -3.223
Return on Invested Capital -3.22

ULBI Capital Structure

Total Debt to Total Equity 40.758
Total Debt to Total Capital 28.956
Total Debt to Total Assets 24.426
Long-Term Debt to Equity 36.834
Long-Term Debt to Total Capital 26.169
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Ultralife Corp. - ULBI

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
131.84M 158.64M 164.46M 191.16M
Sales Growth
+34.17% +20.33% +3.66% +16.24%
Cost of Goods Sold (COGS) incl D&A
103.72M 120.33M 123.17M 146.66M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
4.46M 3.91M 4.16M 5.50M
Depreciation
3.18M 3.02M 3.13M 3.98M
Amortization of Intangibles
1.28M 889.00K 1.03M 1.52M
COGS Growth
+39.68% +16.01% +2.36% +19.06%
Gross Income
28.12M 38.31M 41.28M 44.50M
Gross Income Growth
+17.11% +36.25% +7.75% +7.80%
Gross Profit Margin
+21.33% +24.15% +25.10% +23.28%
2022 2023 2024 2025 5-year trend
SG&A Expense
27.99M 28.84M 31.32M 35.28M
Research & Development
6.98M 7.43M 8.16M 9.00M
Other SG&A
21.00M 21.40M 23.15M 26.28M
SGA Growth
+16.75% +3.03% +8.60% +12.66%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 15.12M
-
EBIT after Unusual Expense
129.00K 9.47M 9.96M (5.90M)
Non Operating Income/Expense
376.00K 1.66M 276.00K 1.46M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
951.00K 2.02M 1.94M 3.95M
Interest Expense Growth
+292.98% +111.99% -3.77% +103.76%
Gross Interest Expense
951.00K 2.02M 1.94M 3.95M
Interest Capitalized
- - - -
-
Pretax Income
(446.00K) 9.12M 8.30M (8.40M)
Pretax Income Growth
-195.36% +2,144.17% -8.95% -201.17%
Pretax Margin
-0.34% +5.75% +5.05% -4.39%
Income Tax
(326.00K) 1.95M 1.89M (2.45M)
Income Tax - Current - Domestic
19.00K 27.00K 50.00K 60.00K
Income Tax - Current - Foreign
617.00K 623.00K 610.00K 34.00K
Income Tax - Deferred - Domestic
(661.00K) 1.47M 1.37M (2.05M)
Income Tax - Deferred - Foreign
(301.00K) (165.00K) (139.00K) (491.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(120.00K) 7.17M 6.41M (5.95M)
Minority Interest Expense
(1.00K) (31.00K) 97.00K (53.00K)
Net Income
(119.00K) 7.20M 6.31M (5.90M)
Net Income Growth
+49.15% +6,147.90% -12.30% -193.44%
Net Margin Growth
-0.09% +4.54% +3.84% -3.09%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(119.00K) 7.20M 6.31M (5.90M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(119.00K) 7.20M 6.31M (5.90M)
EPS (Basic)
-0.0074 0.4439 0.3813 -0.3544
EPS (Basic) Growth
+49.32% +6,098.65% -14.10% -192.95%
Basic Shares Outstanding
16.13M 16.21M 16.55M 16.64M
EPS (Diluted)
-0.0074 0.4436 0.3764 -0.3544
EPS (Diluted) Growth
+49.32% +6,094.59% -15.15% -194.16%
Diluted Shares Outstanding
16.13M 16.23M 16.77M 16.64M
EBITDA
4.59M 13.39M 14.12M 14.72M
EBITDA Growth
+28.37% +191.76% +5.50% +4.23%
EBITDA Margin
+3.48% +8.44% +8.59% +7.70%

Snapshot

Average Recommendation BUY Average Target Price 14.00
Number of Ratings 1 Current Quarters Estimate N/A
FY Report Date N/A Current Year's Estimate N/A
Last Quarter’s Earnings -0.45 Median PE on CY Estimate N/A
Year Ago Earnings -0.35 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates N/A N/A N/A N/A
Mean Estimate N/A N/A N/A N/A
High Estimates N/A N/A N/A N/A
Low Estimate N/A N/A N/A N/A
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Ultralife Corp. - ULBI

Date Name Shares Transaction Value
May 14, 2025 Michael Edward Manna President and CEO; Director 22,874 Open market or private purchase of non-derivative security Non-derivative transaction at $5.29 per share 121,003.46

Ultralife Corp. in the News